P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808
Dive into the research topics of 'P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808'. Together they form a unique fingerprint.
Keyphrases
Nursing and Health Professions
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science